Founded
KANDO id: 123415

Corporate information

Official name
ReVision Therapeutics Incorporated
Registration country

Company type

An ophthalmic biopharmaceutical company developing fenretinide (RT-101) for the treatment of age-related macular degeneration (AMD).

Funding rounds

N/A


( )

Profile Country
Avalon Ventures


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials